期刊文献+

吴茱萸碱抑制Huh7细胞生长并增强细胞对TRAIL的敏感性 被引量:6

Evodiamine inhibits growth of Huh7 cells and enhances their sensitivity to TRAIL
下载PDF
导出
摘要 目的:探讨吴茱萸碱对人肝癌Huh7细胞生长和凋亡的影响,阐明吴茱萸碱促进肿瘤坏死因子凋亡诱导配体(TRAIL)抗肿瘤活性的分子机制。方法:MTT法检测吴茱萸碱对Huh7细胞活力的影响;流式细胞术观察吴茱萸碱对细胞周期的阻滞;TUNEL染色法检测细胞凋亡的变化;Western blot实验测定细胞内细胞周期和凋亡相关蛋白的表达水平。结果:Huh7细胞经吴茱萸碱处理后,细胞活力明显下降(P<0.05);同时,细胞发生G_2/M期阻滞,p27、cyclin B1、细胞分裂周期蛋白2(Cdc2)和p-Cdc2的蛋白水平上调(P<0.05);吴茱萸碱能够诱导Huh7细胞发生凋亡,促进多聚ADP核糖聚合酶(PARP)和caspase-3的切割。当吴茱萸与TRAIL联用后,Huh7细胞活力明显下降,PARP和caspase-3的切割增加;另外,吴茱萸上调Huh7细胞中死亡受体5(DR5)的蛋白水平。结论:吴茱萸碱通过抑制细胞活力和阻滞细胞周期于G_2/M期而抑制细胞生长,并诱导Huh7细胞发生凋亡;上调DR5的表达水平可能与吴茱萸碱增强Huh7细胞对TRAIL的敏感性相关。 AIM: To investigate the effects of evodiamine on the growth and apoptosis of human hepatocellular carcinoma Huh7 cells,and to illustrate the molecular mechanism that evodiamine enhances antitumor activity of tumors necrosis factor-related apoptosis-inducing ligand( TRAIL) in Huh7 cells. METHODS: The cell viability was measured by MTT assay. The cell cycle distribution was analyzed by flow cytometry. The apoptosis rate was determined by TUNEL staining. The protein levels of cell cycle-and apoptosis-related proteins were detected by Western blot analysis. RESULTS:Treatment of Huh7 cells with evodiamine reduced the cell viability( P 〈 0. 05). Evodiamine induced cell cycle arrest in G2/M phase by upregulation of p27,cyclin B1,cell division cycle protein 2( Cdc2) and p-Cdc2. Evodiamine triggered apoptosis accompanied by cleavage of caspase-3 and poly( ADP-ribose) polymerase( PARP). Combination of evodiamine with TRAIL significantly reduced the cell viability and increased cleavage of caspase-3 and PARP as compared with the use of each agent alone. Moreover,evodiamine increased the expression of death receptor 5( DR5) in the Huh7 cells. CONCLUSION: Evodiamine inhibits the cell growth by reducing the cell viability and inducing cell cycle arrest. Evodiamine also triggers cell apoptosis and enhances the sensitivity of Huh7 cells to TRAIL by upregulating the expression of DR5.
作者 张庆然 周昭伶 潘振海 马亚鹏 马志强 费洪荣 ZHANG Qing-ran;ZHOU Zhao-ling;PAN Zhen-hai;MA Ya-peng;MA Zhi-qiang;FEI Hong-rong(School of Pharmacy,Taishan Medical Universit)
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2018年第2期212-217,共6页 Chinese Journal of Pathophysiology
基金 国家自然科学基金资助项目(No.81703039) 山东省高等学校科技计划项目(No.J15LM09) 国家级大学生创新创业训练计划项目(No.201610439113 No.201710439103) 山东省自然科学基金联合专项(No.ZR2016HL58)
关键词 吴茱萸碱 细胞周期 细胞凋亡 肿瘤坏死因子凋亡诱导配体 死亡受体5 Evodiamine Cell cycle Apoptosis Tumor necrosis factor-related apoptosis-inducing ligand Death receptor 5
  • 相关文献

参考文献5

二级参考文献61

  • 1赵云雪,丁杏苞.猪毛菜中生物碱化学成分的研究[J].药学学报,2004,38(8):598-600. 被引量:19
  • 2CHIO Y H,SHIN E M,KIM Y S,et al.Anti-inflammatory principles from the fruits of Evodia rutaecarpa and their cellular action mechanisms[J].Arch Pharm Res,2006,29(4):293-297.
  • 3LIAO J F,CHOU W F,SHEN Y C,et al.Anti-inflammatory and anti-infectious effects of Evodia rutaecarpa(Wuzhuyu)and its major bioactive components[J].Chinese Med,2011,6(6):1-8.
  • 4ADAMS M,MAHRINGER A,KUNERT O,et al.Cytotoxicity and p-glycoprotein modulating effects of quinolones and indoloquinazolines from the Chinese herb Evodia rutaecarpa[J].Planta M ed,2007,73(15):1554-1557.
  • 5LI Hai-bo,ZHOU Chang-xin,PAN Yun-xue,et al.Evaluation of antiviral activity of compounds isolated from Ranunculus sieboldii and Ranunculus sceleratus[J].Planta Med,2005,71(12):1128-1133.
  • 6MUNEHISA A,TAKAHIRO H,TOSHIMITSU H,et al.Studies on constituents of Evodia rutaecarpa(Rutaceae).I.[J].Chem Pharm Bull,1993,41(8):1472-1474.
  • 7CHIU C Y,LI C Y,CHIU C C,et al.Constituents of leaves of Phellodendron japonicum M axim.and their antioxidant activity[J].Chem Pharm Bull,2005,53(9):1118-1121.
  • 8LIU Xiao-qiu,LI Wei-wei,HUA Hui-ming,et al.An NM R study of a phenyl propanoid-substituted catechin from Polygonum bistorta[J].Asian J Trad M ed,2006,1(2):73-75.
  • 9LI Xin,YANG Min,HAN Yi-feng,et al.New sesquiterpenes from Erigeron annus[J].Planta M ed,2005,71(3):268-272.
  • 10TOHRU S,TOSHIO M,MASANORI K,et al.Limonoids and quinolone alkaloids from Evodia rutaecarpa Bentham[J].Chem Pharm Bull,1988,36(11):4453-4461.

共引文献57

同被引文献36

引证文献6

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部